User:Jordana Armstrong
From MyWiki
While ESR1 amplification has been an intense area of investigation underlying endocrine therapy resistance as described above, a study focusing on genomic aberrations of the drug target of AIs, aromatase CYP19A1, has deepened our understanding of endocrine refractory ER breast tumors <a href=http://cialis.boats>generic name for cialis</a>